News
Piramal Pharma Ltd, Anant Raj Ltd, TCI Express Ltd and Avadh Sugar & Energy Ltd will turn ex-date for dividends on Wednesday.
2d
NDTV Profit on MSNDividend Stocks: TCS, Anant Raj, Piramal Pharma And Five More — Last Date To Buy Before Record DateThe eight stocks with July 16 as record date are TCS, Anant Raj, Piramal Pharma, Ultramarine and Pigments, Avadh Sugar, B&A ...
The Riverview site provides comprehensive drug substance development and manufacturing services, including spec ...
MUMBAI, India, March 31, 2021 /PRNewswire/ -- Piramal Pharma Limited's (PPL) Contract Development and Manufacturing Organization (CDMO), Piramal Pharma Solutions (PPS), announced today that PPL ...
-Piramal Pharma Ltd. continúa invirtiendo en EE.UU.; 90 millones de dólares en la expansión de dos plantas en EE.UU. Adición de capacidades de producción de inyectables estériles a escala ...
Piramal Pharma Limited was incorporated on March 4, 2020 as a Public Limited Company and registered with the RoC. The Company offers a portfolio of differentiated products and services through ...
Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceuticals company, today announced its standalone and consolidated results for the First Quarter (Q1) ended 30th June ...
Piramal Pharma has committed to reduce its GHG emissions for Scope 1, 2, and 3 by 2030. MUMBAI, India, Sept. 16, 2024 /PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a ...
Piramal Pharma Ltd. expects new molecule development and an $80 million expansion of its sterile injectable facility in Kentucky to underpin its goal of doubling revenues in the next five years, ...
MUMBAI, India, Oct. 23, 2024 /PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceuticals and wellness company, today announced its standalone and ...
MUMBAI, India, July 26, 2024 /PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceuticals company, today announced its standalone and consolidated ...
MUMBAI, India, May 24, 2023 /CNW/ -- Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), today announced its consolidated results for the fourth quarter (Q4) and full year FY23 ended 31 st ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results